2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Trend test (p-value) | |
---|---|---|---|---|---|---|---|
PP | |||||||
N patients | 29 | 18 | 27 | 28 | 23 | 32 | |
Rate per 1,000 PY | 5,180 | 6,525 | 6,181 | 5,968 | 5,598 | 5,549 | 0.452 |
95% CI | 3,869–6,793 | 4,491–9,163 | 4,602–8,127 | 4,565–7,666 | 4,141–7,401 | 4,334–7,000 | |
ACP | |||||||
N patients | 11,977 | 10,712 | 10,932 | 9,256 | 8,328 | 7,466 | |
Rate per 1,000 PY | 6,363 | 5,893 | 6,125 | 5,750 | 5,367 | 5,380 | 0.060 |
95% CI | 6,274–6,454 | 5,804–5,983 | 6,033–6,218 | 5,655–5,846 | 5,273–5,462 | 5,280–5,482 | |
IPD | |||||||
N patients | NA | 6 | NA | 8 | NA | NA | |
Rate per 1,000 PY | - | 4,490 | - | 3,185 | - | - | 1 |
95% CI | 2,616–7,189 | 1,887–5,033 | |||||
AOM | |||||||
N patients | 45,636 | 44,148 | 43,050 | 38,830 | 37,348 | 35,269 | |
Rate per 1,000 PY | 27,097 | 26,909 | 27,230 | 26,774 | 26,636 | 26,536 | 0.060 |
95% CI | 26,894–27,300 | 26,703–27,117 | 27,018–27,444 | 26,552–26,998 | 26,410–26,865 | 26,302–26,771 | |
AOM simple | |||||||
N patients | 43,852 | 42,574 | 41,480 | 37,459 | 36,145 | 34,223 | |
Rate per 1,000 PY | 27,247 | 27,092 | 27,465 | 26,997 | 26,842 | 26,761 | 0.060 |
95% CI | 27,024–27,472 | 26,866–27,320 | 27,233–27,699 | 26,755–27,241 | 26,597–27,089 | 26,510–27,014 | |
AOM recurrent | |||||||
N patients | 4,983 | 4,562 | 4,273 | 3,656 | 3,268 | 2,546 | |
Rate per 1,000 PY | 26,372 | 25,966 | 25,962 | 25,511 | 25,357 | 24,987 | 0.009 |
95% CI | 25,892–26,859 | 25,465–26,474 | 25,439–26,493 | 24,953–26,079 | 24,765–25,960 | 24,353–25,632 |